Literature DB >> 16083343

Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy.

Oswaldo Rodriguez-Mora1, Michelle M LaHair, Christopher J Howe, James A McCubrey, Richard A Franklin.   

Abstract

In this review the authors discuss the expression and activation of a family of protein kinases known as the calcium/calmodulin-dependent kinases (CaM-kinase) and the role that these kinases have in the activation of antiapoptotic signalling pathways. In addition, the authors outline a novel mechanism of activation of these kinases by oxidative stress. Founded on this novel mechanism of activation and the role that these kinases have in activating antiapoptotic signalling pathways, the authors propose that the CaM-kinases would make very good targets for sensitising cancer cells to certain therapeutic treatments. Furthermore, the authors discuss the role that these kinases have in cell transformation and in the regulation of the cell cycle. Based on these roles the authors suggest that inhibition of the CaM-kinases not only has the potential to sensitise cancer cells, but also has the potential to induce cytostasis in these cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083343     DOI: 10.1517/14728222.9.4.791

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  13 in total

Review 1.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

2.  Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer.

Authors:  Runbi Ji; Bin Zhang; Xu Zhang; Jianguo Xue; Xiao Yuan; Yongmin Yan; Mei Wang; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  Cell Cycle       Date:  2015-06-19       Impact factor: 4.534

Review 3.  Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease.

Authors:  S M Cabarcas; E M Hurt; W L Farrar
Journal:  Curr Mol Med       Date:  2010-11       Impact factor: 2.222

4.  1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.

Authors:  Zehan Chen; Sujatha M Gopalakrishnan; Mai-Ha Bui; Niru B Soni; Usha Warrior; Eric F Johnson; Jennifer B Donnelly; Keith B Glaser
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

Review 5.  Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

Authors:  A Ishida; N Sueyoshi; Y Shigeri; I Kameshita
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

6.  Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Authors:  Stefan Gattenlöhner; Thorsten Stühmer; Ellen Leich; Matthias Reinhard; Benjamin Etschmann; Hans-Ulrich Völker; Andreas Rosenwald; Edgar Serfling; Ralf Christian Bargou; Georg Ertl; Hermann Einsele; Hans-Konrad Müller-Hermelink
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

7.  Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.

Authors:  William H Chappell; Saverio Candido; Stephen L Abrams; Shaw M Akula; Linda S Steelman; Alberto M Martelli; Stefano Ratti; Lucio Cocco; Melchiorre Cervello; Giuseppe Montalto; Ferdinando Nicoletti; Massimo Libra; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-06-03       Impact factor: 5.682

8.  Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure.

Authors:  Yixi Liu; Qun Shao; Heng-Jie Cheng; Tiankai Li; Xiaowei Zhang; Michael F Callahan; David Herrington; Dalane Kitzman; David Zhao; Che-Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2021-03-15       Impact factor: 4.402

9.  A 63 signature genes prediction system is effective for glioblastoma prognosis.

Authors:  Yang Zhang; Jiaming Xu; Xiangdong Zhu
Journal:  Int J Mol Med       Date:  2018-01-25       Impact factor: 4.101

Review 10.  A temporal examination of calcium signaling in cancer- from tumorigenesis, to immune evasion, and metastasis.

Authors:  MengMeng Xu; Andreas Seas; Musa Kiyani; Keven S Y Ji; Hannah N Bell
Journal:  Cell Biosci       Date:  2018-04-03       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.